nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—migraine—Cyproheptadine—allergic rhinitis	0.729	1	CpDpCtD
Naratriptan—HTR1A—Cyproheptadine—allergic rhinitis	0.0947	1	CbGbCtD
Naratriptan—Headache—Cetirizine—allergic rhinitis	0.000118	0.000669	CcSEcCtD
Naratriptan—Vomiting—Flunisolide—allergic rhinitis	0.000118	0.000668	CcSEcCtD
Naratriptan—Rash—Flunisolide—allergic rhinitis	0.000117	0.000662	CcSEcCtD
Naratriptan—Dermatitis—Flunisolide—allergic rhinitis	0.000116	0.000662	CcSEcCtD
Naratriptan—Hypersensitivity—Montelukast—allergic rhinitis	0.000116	0.00066	CcSEcCtD
Naratriptan—Headache—Flunisolide—allergic rhinitis	0.000116	0.000658	CcSEcCtD
Naratriptan—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000115	0.000656	CcSEcCtD
Naratriptan—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000115	0.000656	CcSEcCtD
Naratriptan—Bradycardia—Triamcinolone—allergic rhinitis	0.000115	0.000653	CcSEcCtD
Naratriptan—Bradycardia—Methylprednisolone—allergic rhinitis	0.000115	0.000651	CcSEcCtD
Naratriptan—Haemoglobin—Triamcinolone—allergic rhinitis	0.000113	0.000644	CcSEcCtD
Naratriptan—Haemoglobin—Methylprednisolone—allergic rhinitis	0.000113	0.000643	CcSEcCtD
Naratriptan—Asthenia—Montelukast—allergic rhinitis	0.000113	0.000643	CcSEcCtD
Naratriptan—Haemorrhage—Triamcinolone—allergic rhinitis	0.000113	0.000641	CcSEcCtD
Naratriptan—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000113	0.00064	CcSEcCtD
Naratriptan—Acute coronary syndrome—Dexamethasone—allergic rhinitis	0.000112	0.000639	CcSEcCtD
Naratriptan—Acute coronary syndrome—Betamethasone—allergic rhinitis	0.000112	0.000639	CcSEcCtD
Naratriptan—Hallucination—Methylprednisolone—allergic rhinitis	0.000112	0.000637	CcSEcCtD
Naratriptan—Myocardial infarction—Dexamethasone—allergic rhinitis	0.000112	0.000635	CcSEcCtD
Naratriptan—Myocardial infarction—Betamethasone—allergic rhinitis	0.000112	0.000635	CcSEcCtD
Naratriptan—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000112	0.000635	CcSEcCtD
Naratriptan—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000112	0.000635	CcSEcCtD
Naratriptan—Nausea—Cetirizine—allergic rhinitis	0.000112	0.000635	CcSEcCtD
Naratriptan—Pruritus—Montelukast—allergic rhinitis	0.000112	0.000634	CcSEcCtD
Naratriptan—Nausea—Flunisolide—allergic rhinitis	0.00011	0.000624	CcSEcCtD
Naratriptan—Arrhythmia—Prednisolone—allergic rhinitis	0.00011	0.000623	CcSEcCtD
Naratriptan—Immune system disorder—Hydrocortisone—allergic rhinitis	0.000108	0.000615	CcSEcCtD
Naratriptan—Diarrhoea—Montelukast—allergic rhinitis	0.000108	0.000613	CcSEcCtD
Naratriptan—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000107	0.000608	CcSEcCtD
Naratriptan—Erythema—Prednisolone—allergic rhinitis	0.000107	0.000607	CcSEcCtD
Naratriptan—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.000104	0.000594	CcSEcCtD
Naratriptan—Erythema—Hydrocortisone—allergic rhinitis	0.000104	0.000593	CcSEcCtD
Naratriptan—Dizziness—Montelukast—allergic rhinitis	0.000104	0.000592	CcSEcCtD
Naratriptan—Bradycardia—Dexamethasone—allergic rhinitis	0.000104	0.000592	CcSEcCtD
Naratriptan—Bradycardia—Betamethasone—allergic rhinitis	0.000104	0.000592	CcSEcCtD
Naratriptan—Haemoglobin—Betamethasone—allergic rhinitis	0.000103	0.000585	CcSEcCtD
Naratriptan—Haemoglobin—Dexamethasone—allergic rhinitis	0.000103	0.000585	CcSEcCtD
Naratriptan—Haemorrhage—Dexamethasone—allergic rhinitis	0.000102	0.000582	CcSEcCtD
Naratriptan—Haemorrhage—Betamethasone—allergic rhinitis	0.000102	0.000582	CcSEcCtD
Naratriptan—Angiopathy—Methylprednisolone—allergic rhinitis	0.000102	0.00058	CcSEcCtD
Naratriptan—Hallucination—Betamethasone—allergic rhinitis	0.000102	0.000579	CcSEcCtD
Naratriptan—Hallucination—Dexamethasone—allergic rhinitis	0.000102	0.000579	CcSEcCtD
Naratriptan—Immune system disorder—Methylprednisolone—allergic rhinitis	0.000102	0.000578	CcSEcCtD
Naratriptan—Arrhythmia—Triamcinolone—allergic rhinitis	0.000101	0.000573	CcSEcCtD
Naratriptan—Vision blurred—Prednisolone—allergic rhinitis	0.000101	0.000572	CcSEcCtD
Naratriptan—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000101	0.000571	CcSEcCtD
Naratriptan—Vomiting—Montelukast—allergic rhinitis	0.0001	0.00057	CcSEcCtD
Naratriptan—Rash—Montelukast—allergic rhinitis	9.94e-05	0.000565	CcSEcCtD
Naratriptan—Dermatitis—Montelukast—allergic rhinitis	9.93e-05	0.000564	CcSEcCtD
Naratriptan—Ill-defined disorder—Prednisolone—allergic rhinitis	9.91e-05	0.000563	CcSEcCtD
Naratriptan—Headache—Montelukast—allergic rhinitis	9.88e-05	0.000561	CcSEcCtD
Naratriptan—Erythema—Triamcinolone—allergic rhinitis	9.82e-05	0.000558	CcSEcCtD
Naratriptan—Erythema—Methylprednisolone—allergic rhinitis	9.8e-05	0.000557	CcSEcCtD
Naratriptan—Ill-defined disorder—Hydrocortisone—allergic rhinitis	9.68e-05	0.00055	CcSEcCtD
Naratriptan—Malaise—Prednisolone—allergic rhinitis	9.63e-05	0.000547	CcSEcCtD
Naratriptan—Vertigo—Prednisolone—allergic rhinitis	9.6e-05	0.000545	CcSEcCtD
Naratriptan—Syncope—Prednisolone—allergic rhinitis	9.58e-05	0.000544	CcSEcCtD
Naratriptan—Malaise—Hydrocortisone—allergic rhinitis	9.41e-05	0.000535	CcSEcCtD
Naratriptan—Loss of consciousness—Prednisolone—allergic rhinitis	9.39e-05	0.000533	CcSEcCtD
Naratriptan—Vertigo—Hydrocortisone—allergic rhinitis	9.37e-05	0.000533	CcSEcCtD
Naratriptan—Nausea—Montelukast—allergic rhinitis	9.36e-05	0.000532	CcSEcCtD
Naratriptan—Syncope—Hydrocortisone—allergic rhinitis	9.35e-05	0.000532	CcSEcCtD
Naratriptan—Angiopathy—Betamethasone—allergic rhinitis	9.29e-05	0.000528	CcSEcCtD
Naratriptan—Angiopathy—Dexamethasone—allergic rhinitis	9.29e-05	0.000528	CcSEcCtD
Naratriptan—Convulsion—Prednisolone—allergic rhinitis	9.25e-05	0.000526	CcSEcCtD
Naratriptan—Loss of consciousness—Hydrocortisone—allergic rhinitis	9.17e-05	0.000521	CcSEcCtD
Naratriptan—Arrhythmia—Dexamethasone—allergic rhinitis	9.15e-05	0.00052	CcSEcCtD
Naratriptan—Arrhythmia—Betamethasone—allergic rhinitis	9.15e-05	0.00052	CcSEcCtD
Naratriptan—Ill-defined disorder—Triamcinolone—allergic rhinitis	9.11e-05	0.000518	CcSEcCtD
Naratriptan—Ill-defined disorder—Methylprednisolone—allergic rhinitis	9.09e-05	0.000517	CcSEcCtD
Naratriptan—Alopecia—Betamethasone—allergic rhinitis	9.05e-05	0.000514	CcSEcCtD
Naratriptan—Alopecia—Dexamethasone—allergic rhinitis	9.05e-05	0.000514	CcSEcCtD
Naratriptan—Convulsion—Hydrocortisone—allergic rhinitis	9.04e-05	0.000514	CcSEcCtD
Naratriptan—Discomfort—Prednisolone—allergic rhinitis	8.98e-05	0.000511	CcSEcCtD
Naratriptan—Erythema—Dexamethasone—allergic rhinitis	8.91e-05	0.000506	CcSEcCtD
Naratriptan—Erythema—Betamethasone—allergic rhinitis	8.91e-05	0.000506	CcSEcCtD
Naratriptan—Myalgia—Hydrocortisone—allergic rhinitis	8.88e-05	0.000505	CcSEcCtD
Naratriptan—Malaise—Triamcinolone—allergic rhinitis	8.86e-05	0.000503	CcSEcCtD
Naratriptan—Anxiety—Hydrocortisone—allergic rhinitis	8.85e-05	0.000503	CcSEcCtD
Naratriptan—Malaise—Methylprednisolone—allergic rhinitis	8.84e-05	0.000502	CcSEcCtD
Naratriptan—Vertigo—Triamcinolone—allergic rhinitis	8.82e-05	0.000501	CcSEcCtD
Naratriptan—Syncope—Triamcinolone—allergic rhinitis	8.81e-05	0.000501	CcSEcCtD
Naratriptan—Vertigo—Methylprednisolone—allergic rhinitis	8.8e-05	0.0005	CcSEcCtD
Naratriptan—Syncope—Methylprednisolone—allergic rhinitis	8.79e-05	0.000499	CcSEcCtD
Naratriptan—Discomfort—Hydrocortisone—allergic rhinitis	8.77e-05	0.000499	CcSEcCtD
Naratriptan—Oedema—Prednisolone—allergic rhinitis	8.72e-05	0.000495	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisolone—allergic rhinitis	8.72e-05	0.000495	CcSEcCtD
Naratriptan—Loss of consciousness—Triamcinolone—allergic rhinitis	8.63e-05	0.000491	CcSEcCtD
Naratriptan—Loss of consciousness—Methylprednisolone—allergic rhinitis	8.61e-05	0.000489	CcSEcCtD
Naratriptan—Shock—Prednisolone—allergic rhinitis	8.58e-05	0.000487	CcSEcCtD
Naratriptan—Cough—Triamcinolone—allergic rhinitis	8.57e-05	0.000487	CcSEcCtD
Naratriptan—Anaphylactic shock—Hydrocortisone—allergic rhinitis	8.51e-05	0.000484	CcSEcCtD
Naratriptan—Oedema—Hydrocortisone—allergic rhinitis	8.51e-05	0.000484	CcSEcCtD
Naratriptan—Convulsion—Triamcinolone—allergic rhinitis	8.51e-05	0.000484	CcSEcCtD
Naratriptan—Convulsion—Methylprednisolone—allergic rhinitis	8.49e-05	0.000483	CcSEcCtD
Naratriptan—Infection—Hydrocortisone—allergic rhinitis	8.46e-05	0.000481	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisolone—allergic rhinitis	8.43e-05	0.000479	CcSEcCtD
Naratriptan—Shock—Hydrocortisone—allergic rhinitis	8.38e-05	0.000476	CcSEcCtD
Naratriptan—Myalgia—Triamcinolone—allergic rhinitis	8.36e-05	0.000475	CcSEcCtD
Naratriptan—Nervous system disorder—Hydrocortisone—allergic rhinitis	8.35e-05	0.000474	CcSEcCtD
Naratriptan—Arthralgia—Methylprednisolone—allergic rhinitis	8.34e-05	0.000474	CcSEcCtD
Naratriptan—Myalgia—Methylprednisolone—allergic rhinitis	8.34e-05	0.000474	CcSEcCtD
Naratriptan—Anxiety—Methylprednisolone—allergic rhinitis	8.31e-05	0.000472	CcSEcCtD
Naratriptan—Skin disorder—Hydrocortisone—allergic rhinitis	8.27e-05	0.00047	CcSEcCtD
Naratriptan—Ill-defined disorder—Betamethasone—allergic rhinitis	8.27e-05	0.00047	CcSEcCtD
Naratriptan—Ill-defined disorder—Dexamethasone—allergic rhinitis	8.27e-05	0.00047	CcSEcCtD
Naratriptan—Discomfort—Triamcinolone—allergic rhinitis	8.26e-05	0.000469	CcSEcCtD
Naratriptan—Discomfort—Methylprednisolone—allergic rhinitis	8.24e-05	0.000468	CcSEcCtD
Naratriptan—Hyperhidrosis—Hydrocortisone—allergic rhinitis	8.23e-05	0.000468	CcSEcCtD
Naratriptan—Dry mouth—Triamcinolone—allergic rhinitis	8.18e-05	0.000465	CcSEcCtD
Naratriptan—Confusional state—Methylprednisolone—allergic rhinitis	8.06e-05	0.000458	CcSEcCtD
Naratriptan—Malaise—Dexamethasone—allergic rhinitis	8.04e-05	0.000457	CcSEcCtD
Naratriptan—Malaise—Betamethasone—allergic rhinitis	8.04e-05	0.000457	CcSEcCtD
Naratriptan—Anaphylactic shock—Triamcinolone—allergic rhinitis	8.02e-05	0.000456	CcSEcCtD
Naratriptan—Oedema—Triamcinolone—allergic rhinitis	8.02e-05	0.000456	CcSEcCtD
Naratriptan—Vertigo—Betamethasone—allergic rhinitis	8.01e-05	0.000455	CcSEcCtD
Naratriptan—Vertigo—Dexamethasone—allergic rhinitis	8.01e-05	0.000455	CcSEcCtD
Naratriptan—Anaphylactic shock—Methylprednisolone—allergic rhinitis	8e-05	0.000455	CcSEcCtD
Naratriptan—Syncope—Dexamethasone—allergic rhinitis	7.99e-05	0.000454	CcSEcCtD
Naratriptan—Syncope—Betamethasone—allergic rhinitis	7.99e-05	0.000454	CcSEcCtD
Naratriptan—Infection—Triamcinolone—allergic rhinitis	7.96e-05	0.000453	CcSEcCtD
Naratriptan—Hypotension—Hydrocortisone—allergic rhinitis	7.95e-05	0.000452	CcSEcCtD
Naratriptan—Infection—Methylprednisolone—allergic rhinitis	7.95e-05	0.000452	CcSEcCtD
Naratriptan—Shock—Triamcinolone—allergic rhinitis	7.89e-05	0.000448	CcSEcCtD
Naratriptan—Shock—Methylprednisolone—allergic rhinitis	7.87e-05	0.000447	CcSEcCtD
Naratriptan—Nervous system disorder—Methylprednisolone—allergic rhinitis	7.84e-05	0.000446	CcSEcCtD
Naratriptan—Loss of consciousness—Dexamethasone—allergic rhinitis	7.83e-05	0.000445	CcSEcCtD
Naratriptan—Loss of consciousness—Betamethasone—allergic rhinitis	7.83e-05	0.000445	CcSEcCtD
Naratriptan—Paraesthesia—Prednisolone—allergic rhinitis	7.83e-05	0.000445	CcSEcCtD
Naratriptan—Skin disorder—Methylprednisolone—allergic rhinitis	7.77e-05	0.000441	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	7.76e-05	0.000441	CcSEcCtD
Naratriptan—Hyperhidrosis—Triamcinolone—allergic rhinitis	7.75e-05	0.00044	CcSEcCtD
Naratriptan—Hyperhidrosis—Methylprednisolone—allergic rhinitis	7.73e-05	0.000439	CcSEcCtD
Naratriptan—Convulsion—Dexamethasone—allergic rhinitis	7.72e-05	0.000439	CcSEcCtD
Naratriptan—Convulsion—Betamethasone—allergic rhinitis	7.72e-05	0.000439	CcSEcCtD
Naratriptan—Paraesthesia—Hydrocortisone—allergic rhinitis	7.64e-05	0.000434	CcSEcCtD
Naratriptan—Myalgia—Betamethasone—allergic rhinitis	7.59e-05	0.000431	CcSEcCtD
Naratriptan—Myalgia—Dexamethasone—allergic rhinitis	7.59e-05	0.000431	CcSEcCtD
Naratriptan—Anxiety—Betamethasone—allergic rhinitis	7.56e-05	0.00043	CcSEcCtD
Naratriptan—Anxiety—Dexamethasone—allergic rhinitis	7.56e-05	0.00043	CcSEcCtD
Naratriptan—Discomfort—Dexamethasone—allergic rhinitis	7.5e-05	0.000426	CcSEcCtD
Naratriptan—Discomfort—Betamethasone—allergic rhinitis	7.5e-05	0.000426	CcSEcCtD
Naratriptan—Hypotension—Methylprednisolone—allergic rhinitis	7.47e-05	0.000425	CcSEcCtD
Naratriptan—Pain—Prednisolone—allergic rhinitis	7.45e-05	0.000424	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	7.35e-05	0.000418	CcSEcCtD
Naratriptan—Fatigue—Hydrocortisone—allergic rhinitis	7.34e-05	0.000417	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	7.3e-05	0.000415	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	7.29e-05	0.000414	CcSEcCtD
Naratriptan—Pain—Hydrocortisone—allergic rhinitis	7.28e-05	0.000414	CcSEcCtD
Naratriptan—Anaphylactic shock—Betamethasone—allergic rhinitis	7.27e-05	0.000413	CcSEcCtD
Naratriptan—Oedema—Betamethasone—allergic rhinitis	7.27e-05	0.000413	CcSEcCtD
Naratriptan—Anaphylactic shock—Dexamethasone—allergic rhinitis	7.27e-05	0.000413	CcSEcCtD
Naratriptan—Oedema—Dexamethasone—allergic rhinitis	7.27e-05	0.000413	CcSEcCtD
Naratriptan—Infection—Dexamethasone—allergic rhinitis	7.23e-05	0.000411	CcSEcCtD
Naratriptan—Infection—Betamethasone—allergic rhinitis	7.23e-05	0.000411	CcSEcCtD
Naratriptan—Paraesthesia—Triamcinolone—allergic rhinitis	7.2e-05	0.000409	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisolone—allergic rhinitis	7.18e-05	0.000408	CcSEcCtD
Naratriptan—Paraesthesia—Methylprednisolone—allergic rhinitis	7.18e-05	0.000408	CcSEcCtD
Naratriptan—Shock—Dexamethasone—allergic rhinitis	7.16e-05	0.000407	CcSEcCtD
Naratriptan—Shock—Betamethasone—allergic rhinitis	7.16e-05	0.000407	CcSEcCtD
Naratriptan—Dyspnoea—Triamcinolone—allergic rhinitis	7.15e-05	0.000406	CcSEcCtD
Naratriptan—Nervous system disorder—Betamethasone—allergic rhinitis	7.13e-05	0.000405	CcSEcCtD
Naratriptan—Nervous system disorder—Dexamethasone—allergic rhinitis	7.13e-05	0.000405	CcSEcCtD
Naratriptan—Thrombocytopenia—Dexamethasone—allergic rhinitis	7.12e-05	0.000405	CcSEcCtD
Naratriptan—Thrombocytopenia—Betamethasone—allergic rhinitis	7.12e-05	0.000405	CcSEcCtD
Naratriptan—Hyperhidrosis—Betamethasone—allergic rhinitis	7.03e-05	0.0004	CcSEcCtD
Naratriptan—Hyperhidrosis—Dexamethasone—allergic rhinitis	7.03e-05	0.0004	CcSEcCtD
Naratriptan—Feeling abnormal—Hydrocortisone—allergic rhinitis	7.02e-05	0.000399	CcSEcCtD
Naratriptan—Urticaria—Prednisolone—allergic rhinitis	6.92e-05	0.000394	CcSEcCtD
Naratriptan—Fatigue—Triamcinolone—allergic rhinitis	6.91e-05	0.000393	CcSEcCtD
Naratriptan—Fatigue—Methylprednisolone—allergic rhinitis	6.9e-05	0.000392	CcSEcCtD
Naratriptan—Pain—Triamcinolone—allergic rhinitis	6.85e-05	0.00039	CcSEcCtD
Naratriptan—Hypotension—Dexamethasone—allergic rhinitis	6.8e-05	0.000386	CcSEcCtD
Naratriptan—Hypotension—Betamethasone—allergic rhinitis	6.8e-05	0.000386	CcSEcCtD
Naratriptan—Urticaria—Hydrocortisone—allergic rhinitis	6.76e-05	0.000384	CcSEcCtD
Naratriptan—Body temperature increased—Hydrocortisone—allergic rhinitis	6.73e-05	0.000382	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	6.63e-05	0.000377	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	6.63e-05	0.000377	CcSEcCtD
Naratriptan—Feeling abnormal—Triamcinolone—allergic rhinitis	6.61e-05	0.000375	CcSEcCtD
Naratriptan—Feeling abnormal—Methylprednisolone—allergic rhinitis	6.59e-05	0.000375	CcSEcCtD
Naratriptan—Paraesthesia—Dexamethasone—allergic rhinitis	6.53e-05	0.000371	CcSEcCtD
Naratriptan—Paraesthesia—Betamethasone—allergic rhinitis	6.53e-05	0.000371	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisolone—allergic rhinitis	6.42e-05	0.000365	CcSEcCtD
Naratriptan—Urticaria—Triamcinolone—allergic rhinitis	6.37e-05	0.000362	CcSEcCtD
Naratriptan—Urticaria—Methylprednisolone—allergic rhinitis	6.35e-05	0.000361	CcSEcCtD
Naratriptan—Body temperature increased—Triamcinolone—allergic rhinitis	6.34e-05	0.00036	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Betamethasone—allergic rhinitis	6.28e-05	0.000357	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	6.28e-05	0.000357	CcSEcCtD
Naratriptan—Hypersensitivity—Hydrocortisone—allergic rhinitis	6.27e-05	0.000356	CcSEcCtD
Naratriptan—Fatigue—Dexamethasone—allergic rhinitis	6.27e-05	0.000356	CcSEcCtD
Naratriptan—Fatigue—Betamethasone—allergic rhinitis	6.27e-05	0.000356	CcSEcCtD
Naratriptan—Pain—Betamethasone—allergic rhinitis	6.22e-05	0.000353	CcSEcCtD
Naratriptan—Pain—Dexamethasone—allergic rhinitis	6.22e-05	0.000353	CcSEcCtD
Naratriptan—Asthenia—Hydrocortisone—allergic rhinitis	6.11e-05	0.000347	CcSEcCtD
Naratriptan—Pruritus—Hydrocortisone—allergic rhinitis	6.02e-05	0.000342	CcSEcCtD
Naratriptan—Feeling abnormal—Betamethasone—allergic rhinitis	5.99e-05	0.000341	CcSEcCtD
Naratriptan—Feeling abnormal—Dexamethasone—allergic rhinitis	5.99e-05	0.000341	CcSEcCtD
Naratriptan—Hypersensitivity—Triamcinolone—allergic rhinitis	5.91e-05	0.000336	CcSEcCtD
Naratriptan—Hypersensitivity—Methylprednisolone—allergic rhinitis	5.89e-05	0.000335	CcSEcCtD
Naratriptan—Diarrhoea—Hydrocortisone—allergic rhinitis	5.82e-05	0.000331	CcSEcCtD
Naratriptan—Urticaria—Dexamethasone—allergic rhinitis	5.78e-05	0.000328	CcSEcCtD
Naratriptan—Urticaria—Betamethasone—allergic rhinitis	5.78e-05	0.000328	CcSEcCtD
Naratriptan—Dizziness—Prednisolone—allergic rhinitis	5.76e-05	0.000328	CcSEcCtD
Naratriptan—Asthenia—Triamcinolone—allergic rhinitis	5.75e-05	0.000327	CcSEcCtD
Naratriptan—Body temperature increased—Betamethasone—allergic rhinitis	5.75e-05	0.000327	CcSEcCtD
Naratriptan—Body temperature increased—Dexamethasone—allergic rhinitis	5.75e-05	0.000327	CcSEcCtD
Naratriptan—Asthenia—Methylprednisolone—allergic rhinitis	5.74e-05	0.000326	CcSEcCtD
Naratriptan—Pruritus—Triamcinolone—allergic rhinitis	5.67e-05	0.000322	CcSEcCtD
Naratriptan—Pruritus—Methylprednisolone—allergic rhinitis	5.66e-05	0.000322	CcSEcCtD
Naratriptan—Dizziness—Hydrocortisone—allergic rhinitis	5.63e-05	0.00032	CcSEcCtD
Naratriptan—Rash—Prednisolone—allergic rhinitis	5.5e-05	0.000312	CcSEcCtD
Naratriptan—Dermatitis—Prednisolone—allergic rhinitis	5.49e-05	0.000312	CcSEcCtD
Naratriptan—Diarrhoea—Methylprednisolone—allergic rhinitis	5.47e-05	0.000311	CcSEcCtD
Naratriptan—Headache—Prednisolone—allergic rhinitis	5.46e-05	0.00031	CcSEcCtD
Naratriptan—Vomiting—Hydrocortisone—allergic rhinitis	5.41e-05	0.000308	CcSEcCtD
Naratriptan—Rash—Hydrocortisone—allergic rhinitis	5.37e-05	0.000305	CcSEcCtD
Naratriptan—Dermatitis—Hydrocortisone—allergic rhinitis	5.36e-05	0.000305	CcSEcCtD
Naratriptan—Headache—Hydrocortisone—allergic rhinitis	5.33e-05	0.000303	CcSEcCtD
Naratriptan—Dizziness—Triamcinolone—allergic rhinitis	5.3e-05	0.000301	CcSEcCtD
Naratriptan—Dizziness—Methylprednisolone—allergic rhinitis	5.29e-05	0.000301	CcSEcCtD
Naratriptan—Asthenia—Dexamethasone—allergic rhinitis	5.22e-05	0.000297	CcSEcCtD
Naratriptan—Asthenia—Betamethasone—allergic rhinitis	5.22e-05	0.000297	CcSEcCtD
Naratriptan—Nausea—Prednisolone—allergic rhinitis	5.18e-05	0.000294	CcSEcCtD
Naratriptan—Pruritus—Dexamethasone—allergic rhinitis	5.15e-05	0.000292	CcSEcCtD
Naratriptan—Pruritus—Betamethasone—allergic rhinitis	5.15e-05	0.000292	CcSEcCtD
Naratriptan—Vomiting—Triamcinolone—allergic rhinitis	5.1e-05	0.00029	CcSEcCtD
Naratriptan—Vomiting—Methylprednisolone—allergic rhinitis	5.09e-05	0.000289	CcSEcCtD
Naratriptan—Nausea—Hydrocortisone—allergic rhinitis	5.06e-05	0.000287	CcSEcCtD
Naratriptan—Rash—Triamcinolone—allergic rhinitis	5.05e-05	0.000287	CcSEcCtD
Naratriptan—Dermatitis—Triamcinolone—allergic rhinitis	5.05e-05	0.000287	CcSEcCtD
Naratriptan—Rash—Methylprednisolone—allergic rhinitis	5.04e-05	0.000287	CcSEcCtD
Naratriptan—Dermatitis—Methylprednisolone—allergic rhinitis	5.04e-05	0.000286	CcSEcCtD
Naratriptan—Headache—Triamcinolone—allergic rhinitis	5.02e-05	0.000285	CcSEcCtD
Naratriptan—Headache—Methylprednisolone—allergic rhinitis	5.01e-05	0.000285	CcSEcCtD
Naratriptan—Diarrhoea—Betamethasone—allergic rhinitis	4.98e-05	0.000283	CcSEcCtD
Naratriptan—Diarrhoea—Dexamethasone—allergic rhinitis	4.98e-05	0.000283	CcSEcCtD
Naratriptan—Dizziness—Dexamethasone—allergic rhinitis	4.81e-05	0.000273	CcSEcCtD
Naratriptan—Dizziness—Betamethasone—allergic rhinitis	4.81e-05	0.000273	CcSEcCtD
Naratriptan—Nausea—Triamcinolone—allergic rhinitis	4.76e-05	0.000271	CcSEcCtD
Naratriptan—Nausea—Methylprednisolone—allergic rhinitis	4.75e-05	0.00027	CcSEcCtD
Naratriptan—Vomiting—Dexamethasone—allergic rhinitis	4.62e-05	0.000263	CcSEcCtD
Naratriptan—Vomiting—Betamethasone—allergic rhinitis	4.62e-05	0.000263	CcSEcCtD
Naratriptan—Rash—Dexamethasone—allergic rhinitis	4.59e-05	0.000261	CcSEcCtD
Naratriptan—Rash—Betamethasone—allergic rhinitis	4.59e-05	0.000261	CcSEcCtD
Naratriptan—Dermatitis—Betamethasone—allergic rhinitis	4.58e-05	0.00026	CcSEcCtD
Naratriptan—Dermatitis—Dexamethasone—allergic rhinitis	4.58e-05	0.00026	CcSEcCtD
Naratriptan—Headache—Dexamethasone—allergic rhinitis	4.56e-05	0.000259	CcSEcCtD
Naratriptan—Headache—Betamethasone—allergic rhinitis	4.56e-05	0.000259	CcSEcCtD
Naratriptan—Nausea—Dexamethasone—allergic rhinitis	4.32e-05	0.000246	CcSEcCtD
Naratriptan—Nausea—Betamethasone—allergic rhinitis	4.32e-05	0.000246	CcSEcCtD
Naratriptan—HTR1F—G alpha (i) signalling events—PTGDR2—allergic rhinitis	2.68e-06	0.0327	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	2.48e-06	0.0303	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	2.13e-06	0.026	CbGpPWpGaD
Naratriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.95e-06	0.0238	CbGpPWpGaD
Naratriptan—HTR1D—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.71e-06	0.0209	CbGpPWpGaD
Naratriptan—HTR1B—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.67e-06	0.0205	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.67e-06	0.0204	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—PTGDR2—allergic rhinitis	1.62e-06	0.0198	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.61e-06	0.0197	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.59e-06	0.0194	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.55e-06	0.019	CbGpPWpGaD
Naratriptan—MAOA—Melatonin metabolism and effects—NFKB1—allergic rhinitis	1.47e-06	0.0179	CbGpPWpGaD
Naratriptan—MAOA—Oxidative Stress—NFKB1—allergic rhinitis	1.43e-06	0.0174	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.36e-06	0.0166	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.33e-06	0.0163	CbGpPWpGaD
Naratriptan—HTR1A—G alpha (i) signalling events—PTGDR2—allergic rhinitis	1.28e-06	0.0156	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—CYSLTR1—allergic rhinitis	1.27e-06	0.0155	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL13—allergic rhinitis	1.25e-06	0.0152	CbGpPWpGaD
Naratriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.25e-06	0.0152	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—CCL11—allergic rhinitis	1.23e-06	0.015	CbGpPWpGaD
Naratriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	1.22e-06	0.0149	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—PTGDR2—allergic rhinitis	1.18e-06	0.0145	CbGpPWpGaD
Naratriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	1.17e-06	0.0143	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	1.15e-06	0.014	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.07e-06	0.013	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL13—allergic rhinitis	1.06e-06	0.0129	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	1.05e-06	0.0128	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—PTGDR2—allergic rhinitis	1.04e-06	0.0126	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.03e-06	0.0126	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGDR2—allergic rhinitis	1.01e-06	0.0124	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—PTGDR2—allergic rhinitis	1.01e-06	0.0124	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	1.01e-06	0.0123	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	9.75e-07	0.0119	CbGpPWpGaD
Naratriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CYSLTR1—allergic rhinitis	9.29e-07	0.0113	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PTGDR2—allergic rhinitis	9.15e-07	0.0112	CbGpPWpGaD
Naratriptan—HTR1F—GPCR ligand binding—TAC1—allergic rhinitis	8.92e-07	0.0109	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PTGDR2—allergic rhinitis	8.31e-07	0.0101	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CYSLTR1—allergic rhinitis	8.13e-07	0.00992	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CYSLTR1—allergic rhinitis	7.96e-07	0.00972	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CYSLTR1—allergic rhinitis	7.96e-07	0.00972	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—CCL11—allergic rhinitis	7.85e-07	0.00958	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—IL10—allergic rhinitis	7.8e-07	0.00952	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—PTGDR2—allergic rhinitis	7.73e-07	0.00943	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—allergic rhinitis	7.69e-07	0.00939	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—CCL11—allergic rhinitis	7.69e-07	0.00938	CbGpPWpGaD
Naratriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.49e-07	0.00914	CbGpPWpGaD
Naratriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	7.33e-07	0.00895	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—CYSLTR1—allergic rhinitis	7.18e-07	0.00877	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—IL10—allergic rhinitis	6.63e-07	0.00809	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CYSLTR1—allergic rhinitis	6.52e-07	0.00796	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—CCL11—allergic rhinitis	6.3e-07	0.00769	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CYSLTR1—allergic rhinitis	6.06e-07	0.0074	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—CCL11—allergic rhinitis	5.85e-07	0.00715	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PTGDR2—allergic rhinitis	5.85e-07	0.00715	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PTGDR2—allergic rhinitis	5.73e-07	0.007	CbGpPWpGaD
Naratriptan—HTR1D—GPCR ligand binding—TAC1—allergic rhinitis	5.7e-07	0.00696	CbGpPWpGaD
Naratriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	5.59e-07	0.00682	CbGpPWpGaD
Naratriptan—HTR1B—GPCR ligand binding—TAC1—allergic rhinitis	5.58e-07	0.00682	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PTGDR2—allergic rhinitis	5.32e-07	0.00649	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PTGDR2—allergic rhinitis	5.2e-07	0.00635	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—TAC1—allergic rhinitis	5.04e-07	0.00615	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTGDR2—allergic rhinitis	4.91e-07	0.00599	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—IL5—allergic rhinitis	4.69e-07	0.00572	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.59e-07	0.00561	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—TAC1—allergic rhinitis	4.58e-07	0.00559	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.5e-07	0.00549	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.37e-07	0.00533	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—IL5—allergic rhinitis	4.25e-07	0.00519	CbGpPWpGaD
Naratriptan—HTR1A—GPCR ligand binding—TAC1—allergic rhinitis	4.25e-07	0.00519	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.17e-07	0.00509	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.08e-07	0.00499	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CCL11—allergic rhinitis	4.03e-07	0.00492	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PTGDR2—allergic rhinitis	3.96e-07	0.00484	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CCL11—allergic rhinitis	3.94e-07	0.00482	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CYSLTR1—allergic rhinitis	3.85e-07	0.0047	CbGpPWpGaD
Naratriptan—MAOA—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	3.82e-07	0.00466	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CCL11—allergic rhinitis	3.72e-07	0.00454	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.43e-07	0.00418	CbGpPWpGaD
Naratriptan—HTR1A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	3.24e-07	0.00396	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—TAC1—allergic rhinitis	3.22e-07	0.00394	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—TAC1—allergic rhinitis	3.16e-07	0.00385	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTGDR2—allergic rhinitis	3.14e-07	0.00383	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.11e-07	0.0038	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTGDR2—allergic rhinitis	3.07e-07	0.00375	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CCL11—allergic rhinitis	3e-07	0.00367	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL5—allergic rhinitis	3e-07	0.00366	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL5—allergic rhinitis	2.93e-07	0.00358	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—TAC1—allergic rhinitis	2.93e-07	0.00357	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—TAC1—allergic rhinitis	2.87e-07	0.0035	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL5—allergic rhinitis	2.72e-07	0.00332	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TAC1—allergic rhinitis	2.7e-07	0.0033	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL5—allergic rhinitis	2.66e-07	0.00325	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL5—allergic rhinitis	2.51e-07	0.00307	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CYSLTR1—allergic rhinitis	2.46e-07	0.00301	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.41e-07	0.00295	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—TAC1—allergic rhinitis	2.4e-07	0.00294	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CCL11—allergic rhinitis	2.38e-07	0.00291	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTGDR2—allergic rhinitis	2.34e-07	0.00286	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CCL11—allergic rhinitis	2.33e-07	0.00284	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL5—allergic rhinitis	2.23e-07	0.00273	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—TAC1—allergic rhinitis	2.18e-07	0.00267	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL5—allergic rhinitis	2.03e-07	0.00248	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.84e-07	0.00224	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CCL11—allergic rhinitis	1.77e-07	0.00217	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—SMAD3—allergic rhinitis	1.77e-07	0.00216	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TAC1—allergic rhinitis	1.73e-07	0.00211	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TAC1—allergic rhinitis	1.69e-07	0.00207	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL5—allergic rhinitis	1.61e-07	0.00196	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL5—allergic rhinitis	1.57e-07	0.00192	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TAC1—allergic rhinitis	1.29e-07	0.00157	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL5—allergic rhinitis	1.2e-07	0.00146	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SMAD3—allergic rhinitis	1.13e-07	0.00138	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SMAD3—allergic rhinitis	1.11e-07	0.00135	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NFKB1—allergic rhinitis	8.99e-08	0.0011	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SMAD3—allergic rhinitis	8.44e-08	0.00103	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TGFB1—allergic rhinitis	7.49e-08	0.000915	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NFKB1—allergic rhinitis	5.75e-08	0.000702	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NFKB1—allergic rhinitis	5.63e-08	0.000687	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TGFB1—allergic rhinitis	4.79e-08	0.000585	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TGFB1—allergic rhinitis	4.69e-08	0.000573	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NFKB1—allergic rhinitis	4.29e-08	0.000524	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TGFB1—allergic rhinitis	3.57e-08	0.000436	CbGpPWpGaD
